BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31897456)

  • 21. Ratiometric Two-Photon Near-Infrared Probe to Detect DPP IV in Human Plasma, Living Cells, Human Tissues, and Whole Organisms Using Zebrafish.
    Valverde-Pozo J; Paredes JM; Widmann TJ; Griñan-Lison C; Ceccarelli G; Gioiello A; Garcia-Rubiño ME; Marchal JA; Alvarez-Pez JM; Talavera EM
    ACS Sens; 2023 Mar; 8(3):1064-1075. PubMed ID: 36847549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions.
    Sternkopf M; Nagy M; Baaten CCFMJ; Kuijpers MJE; Tullemans BME; Wirth J; Theelen W; Mastenbroek TG; Lehrke M; Winnerling B; Baerts L; Marx N; De Meester I; Döring Y; Cosemans JMEM; Daiber A; Steven S; Jankowski J; Heemskerk JWM; Noels H
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):e65-e77. PubMed ID: 31893947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematopoietic cell- versus enterocyte-derived dipeptidyl peptidase-4 differentially regulates triglyceride excursion in mice.
    Varin EM; Hanson AA; Beaudry JL; Nguyen MA; Cao X; Baggio LL; Mulvihill EE; Drucker DJ
    JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32663193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: Potential impact of dipeptidyl peptidase-4 inhibitors.
    Anderluh M; Kocic G; Tomovic K; Kocic R; Deljanin-Ilic M; Smelcerovic A
    Pharmacol Ther; 2016 Nov; 167():100-107. PubMed ID: 27484974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV.
    Marchetti C; Di Carlo A; Facchiano F; Senatore C; De Cristofaro R; Luzi A; Federici M; Romani M; Napolitano M; Capogrossi MC; Germani A
    Diabetologia; 2012 Jan; 55(1):236-44. PubMed ID: 21656024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A high-throughput screening assay for dipeptidyl peptidase-IV inhibitors using human plasma.
    Zhang J; Qian XK; Song PF; Li XD; Wang AQ; Huo H; Yao JC; Zhang GM; Zou LW
    Anal Methods; 2021 Jun; 13(24):2671-2678. PubMed ID: 34036983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ZY15557, a novel, long acting inhibitor of dipeptidyl peptidase-4, for the treatment of Type 2 diabetes mellitus.
    Jain MR; Joharapurkar AA; Kshirsagar SG; Patel VJ; Bahekar RH; Patel HV; Jadav PA; Patel PR; Desai RC
    Br J Pharmacol; 2017 Jul; 174(14):2346-2357. PubMed ID: 28452143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dipeptidyl peptidase-4 inhibitor promotes wound healing in normoglycemic mice by modulating keratinocyte activity.
    Shih CM; Huang CY; Huang CY; Wang KH; Wei PL; Chang YJ; Fong TH; Pan JL; Lee AW
    Exp Dermatol; 2018 Oct; 27(10):1134-1141. PubMed ID: 30028901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and pharmacological evaluation of highly potent and selective dipeptidyl peptidase-4 inhibitors.
    Jiang T; Zhou Y; Zhu J; Chen Z; Sun P; Zhang Q; Wang Z; Shao Q; Jiang X; Li B; Wang H; Zhu W; Shen J
    Arch Pharm (Weinheim); 2015 Jun; 348(6):399-407. PubMed ID: 25871012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.
    Tajima A; Yamamoto K; Kozakai A; Okumura-Kitajima L; Mita Y; Kitano K; Jingu S; Nakaike S
    Eur J Pharmacol; 2011 Mar; 655(1-3):99-107. PubMed ID: 21262219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in kidney-specific DPP-4 inhibition by linagliptin and sitagliptin.
    Luippold G; Mark M; Klein T; Amann K; Daniel C
    Diabetes Res Clin Pract; 2018 Sep; 143():199-203. PubMed ID: 30031047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Potentials of the DPP-4 Inhibitor Sitagliptin against Ischemia-Reperfusion (I/R) Injury in Rat Ex-Vivo Heart Model.
    Al-Awar A; Almási N; Szabó R; Takacs I; Murlasits Z; Szűcs G; Török S; Pósa A; Varga C; Kupai K
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30340421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NIR fluorescent probe based on a modified rhodol-dye with good water solubility and large Stokes shift for monitoring CO in living systems.
    Hong J; Xia Q; Zhou E; Feng G
    Talanta; 2020 Aug; 215():120914. PubMed ID: 32312458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
    Li N; Wang LJ; Jiang B; Li XQ; Guo CL; Guo SJ; Shi DY
    Eur J Med Chem; 2018 May; 151():145-157. PubMed ID: 29609120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolyl peptidases related to dipeptidyl peptidase IV: potential of specific inhibitors in drug discovery.
    Van der Veken P; Haemers A; Augustyns K
    Curr Top Med Chem; 2007; 7(6):621-35. PubMed ID: 17352682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice.
    Yorifuji N; Inoue T; Iguchi M; Fujiwara K; Kakimoto K; Nouda S; Okada T; Kawakami K; Abe Y; Takeuchi T; Higuchi K
    Oncol Rep; 2016 Feb; 35(2):676-82. PubMed ID: 26573958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilisation of the isobole methodology to study dietary peptide-drug and peptide-peptide interactive effects on dipeptidyl peptidase IV (DPP-IV) inhibition.
    Nongonierma AB; FitzGerald RJ
    Food Funct; 2015 Jan; 6(1):313-20. PubMed ID: 25477187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging drug candidates of dipeptidyl peptidase IV (DPP IV) inhibitor class for the treatment of Type 2 Diabetes.
    Gupta R; Walunj SS; Tokala RK; Parsa KV; Singh SK; Pal M
    Curr Drug Targets; 2009 Jan; 10(1):71-87. PubMed ID: 19149538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dipeptidyl peptidase IV inhibitory peptides generated in Spanish dry-cured ham.
    Gallego M; Aristoy MC; Toldrá F
    Meat Sci; 2014 Feb; 96(2 Pt A):757-61. PubMed ID: 24200567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and potent inhibitory activities of carboxybenzyl-substituted 8-(3-(R)-aminopiperidin-1-yl)-7-(2-chloro/cyanobenzyl)-3-methyl-3,7-dihydro-purine-2,6-diones as dipeptidyl peptidase IV (DPP-IV) inhibitors.
    Mo DW; Dong S; Sun H; Chen JS; Pang JX; Xi BM; Chen WH
    Bioorg Med Chem Lett; 2015 May; 25(9):1872-5. PubMed ID: 25838146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.